Effects Of Korea's New Drug-Pricing System Still Murky
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Nearly a year after the South Korean Health Ministry announced new policies aimed at eradicating bribery and promoting more transparent drug pricing, effects of a new drug-pricing system remain unclear, industry watchers say